youtube_live
Q3 2026 earnings • in 1 day
See detailschevron_right
MDLN:NASDAQ
Medline Inc
$33.63
arrow_upward
+4.70%(+1.51) 1D
$33.60
arrow_downward
-0.09% (-0.030)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MDLN...
Open
$32.34
High
$33.90
Low
$32.26
Mkt. cap
44.21B
Avg. vol.
9.14M
Volume
0.00
P/E ratio
39.77
52-wk high
$50.88
52-wk low
$31.37
EPS
$0.85
Shares outstanding
877.35M
No. of employees
45K
Open
$32.34
High
$33.90
Low
$32.26
Mkt. cap
44.21B
Avg. vol.
9.14M
Volume
0.00
P/E ratio
39.77
52-wk high
$50.88
52-wk low
$31.37
EPS
$0.85
Shares outstanding
877.35M
No. of employees
45K
News stories
From web sources and news partners
About Medline Inc
Analyst ratings
Based on 20 analysts giving stock ratings to MDLN in the past 3 months
Strong buy
Buy
18
Hold
2
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for MDLN in the last 3 months.
Highest
Current $33.63
$55.00 (+63.54%)
Average
$44.59 (+32.59%)
Lowest
$34.00 (+1.10%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Steven Valiquette Mizuho Securities | Buy | Maintained | $45.00 | +33.8% | 10/22/2026 |
Glen Santangelo Barclays | Buy | Maintained | $43.00 | +27.9% | 10/09/2026 |
Michael Cherny Leerink Partners | Buy | Maintained | $43.00 | +27.9% | 10/07/2026 |
Ryan Halsted RBC Capital | Buy | Maintained | $46.00 | +36.8% | 10/06/2026 |
Kevin Caliendo UBS | Buy | Reiterated | $43.00 | +27.9% | 09/25/2026 |
Brandon Vazquez William Blair | Buy | Maintained | - | - | 09/23/2026 |
Jailendra Singh Truist Financial | Buy | Maintained | - | - | 09/22/2026 |
David Larsen BTIG | Buy | Maintained | $55.00 | +63.5% | 08/27/2026 |
Ivan Feinseth Tigress Financial | Buy | Reiterated | $55.00 | +63.5% | 08/14/2026 |
Lisa Gill J.P. Morgan | Buy | Maintained | $46.00 | +36.8% | 08/12/2026 |
Stephen Baxter Wells Fargo | Hold | Reiterated | $34.00 | +1.1% | 08/11/2026 |
Charles Rhyee TD Cowen | Buy | Reiterated | $45.00 | +33.8% | 08/10/2026 |
Andrew Obin Bank of America Securities | Buy | Maintained | - | - | 08/06/2026 |
Eric Coldwell Robert W. Baird | Buy | Maintained | $42.00 | +24.9% | 08/06/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $39.00 | +16% | 08/06/2026 |
Rick Wise Stifel Nicolaus | Buy | Reiterated | $45.00 | +33.8% | 08/06/2026 |
Sean Dodge BMO Capital | Buy | Reiterated | $47.00 | +39.8% | 08/05/2026 |
Erin Wright Morgan Stanley | Buy | Maintained | $48.00 | +42.7% | 08/06/2026 |
Pito Chickering Deutsche Bank | Hold | Reiterated | $37.00 | +10% | 08/06/2026 |
Daniel Grosslight Citi | Buy | Maintained | $45.00 | +33.8% | 08/05/2026 |
Patrick B Donnelly Citi | Buy | Maintained | $45.00 | +33.8% | 08/05/2026 |
Lee Hambright Bernstein | Buy | Reiterated | $54.00 | +60.6% | 05/07/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $53.00 | +57.6% | 05/07/2026 |
David Roman Goldman Sachs | Buy | Maintained | $50.00 | +48.7% | 05/06/2026 |
Jason Bednar Piper Sandler | Buy | Maintained | $55.00 | +63.5% | 05/04/2026 |
Patrick Wood Morgan Stanley | Buy | Maintained | $48.00 | +42.7% | 02/25/2026 |
Next call in 30:49:39
Wed, Nov 4, 9:30 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.35
Revenue / Est. (USD)
- / 7.72B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 7.12B | 7.79B | 7.35B | 7.68B |
Cost of goods sold | 5.24B | 5.87B | 5.51B | 5.80B |
Cost of revenue | 5.24B | 5.87B | 5.51B | 5.80B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 1.12B | 1.26B | 1.23B | 1.30B |
Operating expense | 1.30B | 1.47B | 1.42B | 1.82B |
Total operating expenses | 6.54B | 7.34B | 6.93B | 7.62B |
Operating income | 574.00M | 443.00M | 422.00M | 63.00M |
Other non operating income | - | -6.00M | 1.00M | -42.00M |
EBT including unusual items | 345.00M | 206.00M | 291.00M | 235.00M |
EBT excluding unusual items | 351.00M | 276.00M | 291.00M | -97.00M |
Income tax expense | 23.00M | 26.00M | 52.00M | 96.00M |
Effective tax rate | 6.67% | 12.62% | 17.87% | 40.85% |
Other operating expenses | 8.00M | 30.00M | 15.00M | 348.00M |
Net income | 322.00M | 182.00M | 129.00M | 60.00M |
Net profit margin | 4.53% | 2.34% | 1.75% | 0.78% |
Earnings per share | - | 0.31 | 0.33 | 0.50 |
Interest and investment income | 35.00M | 34.00M | 29.00M | 49.00M |
Interest expense | -248.00M | -200.00M | -165.00M | -168.00M |
Net interest expenses | -213.00M | -166.00M | -136.00M | -119.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 827.00M | 704.00M | 676.00M | 319.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events